Background: Clinical studies have shown that repetitive transcranial magnetic stimulation (rTMS) is effective in a certain percentage of treatment-resistant depression (TRD). The left dorsolateral prefrontal cortex (DLPFC) 10 Hz rTMS stimulation received FDA approval in 2008, although different rTMS protocols have also shown their effectiveness in reducing depressive symptoms. We investigated the clinical, cognitive and neurophysiologic effects of a 3 weeks’ protocol of low-frequency rTMS applied over the right DLPFC in resistant depression. Methods: Twenty-eight patients with TRD (age range 28–55) received low-frequency rTMS (1 Hz) over the right DLPFC in a 3-week open trial. Hamilton scales for depression and anxiety, Corsi block-tapping test, phonemic verbal fluency, right and left resting motor thresholds were evaluated in each subject over the trial period. Results: At the end of the trial 42.9% of the subjects were considered as responders. A significant reduction of both HAMD (p < 0.001) and HAMA (p < 0.01) total scores was observed. At the 3rd week, the performances in Corsi test (p < 0.02) and phonemic verbal fluency (p = 0.065) were improved independently from depressive symptoms variation. At the end of the rTMS protocol, a significantly decreased left hemisphere resting motor threshold was registered (p < 0.01), while right hemisphere resting motor threshold did not show significant variation. Conclusion: Low-frequency rTMS over the right DLPFC appeared effective in 42.9% of depressive resistant subjects in this sample. A significant decrease in left hemisphere resting motor threshold was observed only in responders, while a trend for improvement in cognitive function has been found and appeared independent from clinical response.

Keywords:
Treatment-resistant depression, Cognition, Motor threshold, Transcranial magnetic stimulation
1.
Chen R, Classen J, Gerloff C, Celnik P, Wassermann EM, Hallett M, Cohen LG: Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation. Neurology 1997;48:1398–1403.
2.
Stern WM, Tormos JM, Press DZ, Pearlman C, Pascual-Leone A: Antidepressant effects of high and low frequency repetitive transcranial magnetic stimulation to the dorsolateral prefrontal cortex: a double-blind, randomized, placebo-controlled trial. J Neuropsychiatry Clin Neurosci 2007;19:179–186.
3.
Fitzgerald PB, McQueen S, Herring S, Hoy K, Segrave R, Kulkarni J, Daskalakis ZJ: A randomized trial of the anti-depressant effects of low- and high-frequency transcranial magnetic stimulation in treatment-resistant depression. Depression Anxiety 2009;26:229–234.
4.
Schutter DJ: Quantitative review of the efficacy of slow-frequency magnetic brain stimulation in major depressive disorder. Psychol Med 2010;40:1789–1795.
5.
Fitzgerald PB, Benitez J, De CA, Daskalakis ZJ, Brown TL, Kulkarni J: A randomized controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression. Am J Psychiatry 2006;163:88–94.
6.
Fitzgerald PB, Hoy K, Gunewardene R, Slack C, Ibrahim S, Bailey M, Daskalakis ZJ: A randomized trial of unilateral and bilateral prefrontal cortex transcranial magnetic stimulation in treatment-resistant major depression. Psychol Med 2010;1–10.
7.
Pallanti S: Unilateral low frequency versus sequential bilateral rTMS: is simpler better for treatment of resistant depression? Neuroscience 2010;167:323–328.
8.
Soekadar SR, Arfeller C, Rilk A, Plontke SK, Plewnia C: Theta burst stimulation in the treatment of incapacitating tinnitus accompanied by severe depression. CNS Spectr 2009;14:208–211.
9.
Holzer M, Padberg F: Intermittent theta burst stimulation (iTBS) ameliorates therapy-resistant depression: a case series. Brain Stimul 2010;3:181–183.
10.
Chistyakov AV, Rubicsek O, Kaplan B, Zaaroor M, Klein E: Safety, tolerability and preliminary evidence for antidepressant efficacy of theta-burst transcranial magnetic stimulation in patients with major depression. Int J Neuropsychopharmacol 2010;13:387–393.
11.
Loo C, Martin D, Pigot M, Arul-Anandam P, Mitchell P, Sachdev P: Transcranial direct current stimulation priming of therapeutic repetitive transcranial magnetic stimulation: a pilot study. J ECT 2009;25:256–260.
12.
Rosenberg O, Zangen A, Stryjer R, Kotler M, Dannon PN: Response to deep TMS in depressive patients with previous electroconvulsive treatment. Brain Stimul 2010;3:211–217.
13.
Rosenberg O, Isserles M, Levkovitz Y, Kotler M, Zangen A, Dannon PN: Effectiveness of a second deep TMS in depression: a brief report. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:1041–1044.
14.
Levkovitz Y, Harel EV, Roth Y, Braw Y, Most D, Katz LN, Sheer A, Gersner R, Zangen A: Deep transcranial magnetic stimulation over the prefrontal cortex: evaluation of antidepressant and cognitive effects in depressive patients. Brain Stimul 2009;2:188–200.
15.
Isserles M, Rosenberg O, Dannon P, Levkovitz Y, Kotler M, Deutsch F, Lerer B, Zangen A: Cognitive-emotional reactivation during deep transcranial magnetic stimulation over the prefrontal cortex of depressive patients affects antidepressant outcome. J Affect Disord 2011;128:235–242.
16.
Hamada M, Ugawa Y: Quadripulse stimulation – a new patterned rTMS. Restor Neurol Neurosci 2010;28:419–424.
17.
Squire LR: Memory and electroconvulsive therapy (letter). Am J Psychiatry 1982;139:1221.
18.
Sackeim HA, Portnoy S, Neeley P, Steif BL, Decina P, Malitz S: Cognitive consequences of low-dosage electroconvulsive therapy. Ann NY Acad Sci 1986;462:326–340.
19.
Weiner RD, Rogers HJ, Davidson JR, Squire LR: Effects of stimulus parameters on cognitive side effects. Ann NY Acad Sci 1986;462:315–325.
20.
Triggs WJ, McCoy KJM, Greer R, Rossi F, Bowers D, Kortenkamp S, Nadeau SE, Heilman KM, Goodman WK: Effects of left frontal transcranial magnetic stimulation on depressed mood, cognition, and corticomotor threshold. Biol Psychiatry 1999;45:1440–1446.
21.
Padberg F, Zwanzger P, Thoma H, Kathmann N, Haag C, Greenberg BD, Hampel H, Moller HJ: Repetitive transcranial magnetic stimulation (rTMS) in pharmacotherapy-refractory major depression: comparative study of fast, slow and sham rTMS. Psychiatry Res 1999;88:163–171
22.
Schulze-Rauschenbach SC, Harms U, Schlaepfer TE, Maier W, Falkai F, Wagner M: Distinctive neurocognitive effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in major depression. Br J Psychiatry 2005;186:410–416.
23.
Guse B, Falkai P, Wobrock T: Cognitive effects of high-frequency repetitive transcranial magnetic stimulation: a systematic review. J Neural Transm 2010;117:105–122.
24.
Huang CC, Su TP, Shan IK, Wei IH: Effect of 5 Hz repetitive transcranial magnetic stimulation on cognition during a Go/NoGo task. J Psychiatr Res 2004;38:513–5120.
25.
Jorge RE, Robinson RG, Tateno A, Narushima K, Acion L, Moser L, Arndt S, Chemerinski E: Repetitive transcranial magnetic stimulation as treatment of poststroke depression: a preliminary study. Biol Psychiatry 2004 55:398–405.
26.
Mosimann UP, Schmitt W, Greenberg BD, Kosel M, Müri RM, Berkhoff M, Hess CW, Fisch HU, Schlaepfer TE: Repetitive transcranial magnetic stimulation: a putative add on treatment for major depression in elderly patients. Psychiatr Res 2004;126:123–133.
27.
Boggio PS, Fregni F, Bermpohl F, Mansur CG, Rosa M, Rumi DO, Barbosa ER, Rosa MO, Pascual-Leone A, Rigonatti SP, Marcolin MA, Silva MTA: Effect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson’s disease and concurrent depression. Brief reports. Mov Disord 2005;20:1178–1219.
28.
Sachdev P, Loo C, Mitchell P, Malhi G: Transcranial magnetic stimulation for the deficit syndrome of schizophrenia: a pilot investigation. Psychiatry Clin Neurosci 2005;59:354–357.
29.
Rosa MA, Gattaz WF, Pascual-Leone A, Fregni F, Rosa MO, Rumi DO, Myczkowski M, Silva MF, Mansur C, Rigonatti SP, Teixeira MJ, Marcolin MA: Comparison of repetitive transcranial magnetic stimulation and electroconvulsive therapy in unipolar non-psychotic depression: a randomized single-blind study. Int J Neuropsychopharmacol 2006;9:667–676.
30.
Mogg A, Pluck G, Eranti SV, Landau S, Purvis R, Brown RG, Curtis V, Howard R, Philpot M, McLoughlin DM: A randomized controlled trial with 4-month follow-up of adjunctive repetitive transcranial magnetic stimulation of the left prefrontal cortex for depression. Psychol Med 2008;38:323–333.
31.
Januel D, Dumortier G, Verdon CM, Stamatiadis L, Saba G, Cabaret W, Benadhira R, Rocamora JF, Braha S, Kalalou K, Vicaut PE, Fermanian J: A double-blind sham controlled study of right prefrontal repetitive transcranial magnetic stimulation (rTMS): therapeutic and cognitive effect in medication free unipolar depression during 4 weeks. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:126–130.
32.
Fitzgerald PB, Fountain S, Daskalakis ZJ: A comprehensive review of the effects of rTMS on motor cortical excitability and inhibition. Clin Neurophysiol 2006;117:2584–2596.
33.
Pascual-Leone A, Tormos JM, Keenan J, Tarazona F, Cañete C, Catalá MD: Study and modulation of human cortical excitability with transcranial magnetic stimulation. J Clin Neurophysiol 1998;15:333–343.
34.
Mantovani A, Lisanby SH, Pieraccini F, Ulivelli M, Castrogiovanni P, Rossi S: Repetitive transcranial magnetic stimulation (RTMS) in the treatment of panic disorder (PD) with comorbid major depression. J Affect Disord 2007;102:277–280.
35.
Chistyakov AV, Kaplan B, Rubichek O, Kreinin I, Koren D, Feinsod M, Klein E: Antidepressant effects of different schedules of repetitive transcranial magnetic stimulation vs. clomipramine in patients with major depression: relationship to changes in cortical excitability. Int J Neuropsychopharmacol 2005;8:223–233.
36.
Bajbouj M, Brakemeier EL, Schubert F, Lang UE, Neu P, Schindowski C, Danker-Hopfe H: Repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex and cortical excitability in patients with major depressive disorder. Exp Neurol 2005;196:332–338.
37.
Dolberg OT, Dannon PN, Schreiber S, Grunhaus L: Magnetic motor threshold and response to TMS in major depressive disorder. Acta Psychiatr Scand 2002;106:220–223.
38.
Zarkowski P, Navarro R, Pavlicova M, George MS, Avery D: The effect of daily prefrontal repetitive transcranial magnetic stimulation over several weeks on resting motor threshold. Brain Stimul 2009;2:163–167.
39.
Gorsler A, Bäumer T, Weiller C, Münchau A, Liepert J: Interhemispheric effects of high and low frequency rTMS in healthy humans. Clin Neurophysiol 2003;114:1800–1807.
40.
First M, Spitzer R, Gibbon M, Williams J: Structured Clinical Interview for DSM- IV Axis I Disorders, Clinician Version (SCID-CV). Washington, American Psychiatric Publishing, 1996).
41.
Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56–62.
42.
Thase ME, Rush AJ: When at first you don’t succeed: sequential strategies for antidepressant nonresponders. J Clin Psychiatry 1997;58(suppl 13):23–29.
43.
Sackeim HA, Prudic J, Devanand DP, Nobler MS, Lisanby SH, Peyser S, Fitzsimons L, Moody BJ, Clark J: A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry 2000;57:425–434.
44.
Rossini PM, Berardelli A, Deuschl G, Hallett M, Maertens de Noordhout AM, Paulus W, Pauri F: Applications of magnetic cortical stimulation. The International Federation of Clinical Neurophysiology. Electroencephalogr Clin Neurophysiol Suppl 1999;52:171–185.
45.
Rossi S, Hallett M, Rossini PM, Pascual-Leone A: Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009;120:2008–2039.
46.
De Renzi E, Nichelli P: Verbal and non-verbal short term memory impairment following hemispheric damage. Cortex 1975;11:341–353.
47.
Benton AL: Differential behavioural effects in frontal lobe disease. Neuropsychologia 1968;6:53–60.
48.
Vilkki J, Holst P: Speed and flexibility on word fluency tasks after focal brain lesions. Neuropsychologia 1994;32:1257–1262.
49.
Ruff RM, Light RH, Parker SB, Levin HS: The psychological construct of word fluency. Brain Lang 1997;57:394–405.
50.
Tombaugh TN, Kozak J, Rees L: Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming. Arch Clin Neuropsychol 1999;14:167–177.
51.
Badre D, Wagner AD: Selection, integration, and conflicting monitoring; assessing the nature and generality of prefrontal cognitive control mechanisms. Neuron 2004;41:473–487.
52.
Duncan J: An adaptive coding model of neural function in prefrontal cortex. Nat Rev Neurosci 2001;2:820–829.
53.
Duncan J, Owen AM: Common regions of the human frontal lobe recruited by diverse cognitive demands. Trends Neurosci 2000;23:475–483.
54.
Miller EK, Cohen JD: An integrative theory of prefrontal cortex function. Annu Rev Neurosci 2001;24:167–202.
55.
Sobin C, Sackeim HA: Psychomotor symptoms of depression. Am J Psychiatry 1997;154:4–17.
56.
Schrijvers D, Hulstijn W, Sabbe BGC: Psychomotor symptomsin depression: a diagnostic, pathophysiological and therapeutic tool. J Affect Disord 2008;109:1–20.
57.
Keck ME, Welt T, Mueller MB, et al: Repetitive transcranial magnetic stimulation increases the release of dopamine in mesolimbic and mesostriatal system. Neuropharmacol 2002;43:101–109.
58.
Pogarel O, Koch W, Popperl G, et al: Striatal dopamine release after prefrontal repetitive transcranial magnetic stimulation in major depression: preliminary results of a dynamic [123I]IBZM SPECT study. J Psychiatr Res 2006;40:307–314.
59.
Lefaucheur JP, Lucas B, Andraud F, Hogrel JY, Bellivier F, Del Cul A, Rousseva A, Leboyer M, Paillere-Martinot ML: Inter-hemispheric asymmetry of motor corticospinal excitability in major depression studied by transcranial magnetic stimulation. J Psychiatr Res 2008;42:389–398.
60.
Ziemann U, Steinhoff BJ, Tergau F, Paulus W: Transcranial magnetic stimulation: its current role in epilepsy research. Epilepsy Res 1998;30:11–30.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.